Baudys et al., J. Contr. Rel. vol. 39, pp. 145-51. |
Conradi, R.A., et al., “The Influence of Peptide Structure on Transport Across Caco-2 Cells,” Pharm. Res., 1991, 8 (12): pp. 1453-1459. |
Boccu, E. et al., “Pharmocokinetic Properties of Polyethylene Glycol Derivatized Superoxide Dismutase,” Pharm. Res. comm., 1982, 14: pp. 11-120. |
Igarashi, R. et al., “Biologically Active Peptides Conjugated with Lecithin for DDS” Proceed. Intern. Symp. Cont. Rel. Bioactiv. Mater. 1990, 17: pp. 367-368. |
Taniguchi, T. et al., “Synthesis of Acyloyl Lysozyme and Improvement of its Lymphatic Transport Following Small Intestinal Administration in Rats,” Proceed. Intern. Symp. Control. Rel. Bioactiv. Mater., 1992, 19: pp. 104-105. |
Russell-Jones, G. J., “Vitamin B12 Drug Delivery,” Proceed. Intern. Symp. Control. Rel. Bioactive. Mater., 1992, 19:pp. 102-103. |
Baudys, M. et al., “Synthesis and Characteristics of Different Glycosylated Derivatives of Insulin,” Proceed. Intern. Symp. Cont. Rel. Bioactiv. Mater., 1992, 19: pp. 210-211. |
Chien, Y. W., Novel Drug Delivery Systems, pp. 678-679, Marcell Deffer, Inc., New York, NY, 1992. |
Santiago, N. et al., “Oral Immunization of Rats with Influenze Virus M Protein (M1) Microspheres,” Proceed. Intern. Symp. Cont. Rel. Bioactiv. Mater., 1992, 19: pp. 116-117. |
Banting, R. G., et al., “Pancreatic Extracts in the Treatment of Diabetes Mellitus,” The Canadian Med. Assoc. J. 1922, 12: pp. 141-146. |
Brange, J. et al., “Chemical Stability of Insulin. 1. Hydrolytic Degradation During Storage of Pharmavceutical Preparations,”Pharm. Res., 1992, 9 (6): pp. 715-726. |
Nucci, et al., “The Therapeutic Value of Poly(ethylend glycol)—Modified Proteins,” Ac. Drug. Del. Rev. 1991, 6: pp. 133-151. |
Brange, J. et al., “Chemical Stability of Insulin. 2. Formation of Higher Molecular Weight Transformation Products During Storage of Pharmaceutical Preparations,” Pharm. Res., 1992, 9 (6): pp. 727-734. |
Robbins, D. C. et al., “Antibodies to Covalent Aggregates of Insulin in Blood of Insulin-Using Diabetic Patients,” Diabetes, 1987, 36: pp. 838-841. |
Maislos, M. et al., “The Source of the Circulating Aggregate of Insulin in Type I Diabetic Patients is Therapeutic Insulin,” J. Clin. Invest., 1986, 77: pp. 717-723. |
Ratner, R. E. et al., “Persistent Cutaneous Insulin Allergy Resulting from High-Molecular Weight Insulin Aggregates,” Diabetes, 1990, 39: pp. 728-733. |
Oka, K. et al., “Enhanced Intestinal Absorption of a Hydrophobic Polymer-Conjugated Protein Drug, Smancs, in an Oily Formulation,” Pharm. Res., 1990, 7 (8): pp. 852-855. |
Saffran, M. et al., “A New Approach to the Oral Administration of Insulin and Other Peptide Drugs,” Science, 1986, 233: pp. 1081-1084. |
Abuchowski, A. and F. F. Davis, “Soluble Polymer-Enzyme Adducts,” pp. 368-383, Enzymes as Drugs, J. S. Holcenberg, John Wiley, 1981. |
Akiyama, M. et al., “The Synthesis of New Derivatives of 1-β-D-Arabinofuranosylcytosine,” Chem. Pharm. Bull., 1978, 26(3): p. 981. |
Gish, D. T. et al., “Nucleic Acids. 11. Synthesis of 5′-Esters of 1-β-D-Arabinofuranosylcytosine Possessing Antileukemic and Immunosuppressive Activity,” J. Med. Chem., 1971, 14(12): pp. 1159-1162. |
Baker, D. C. et al., “Prodrugs of 9-β-D-Arabinofuranosyladenine. 1. Synthesis and Evaluation of Some 5′-(O-Acyl) Derivatives,” J. Med. Chem., 1978, 21(12): pp. 1218-1221. |
Hostetler, K. Y. et al., “Synthesis and Antiretroviral Activity of Phospholipid Analogs of Azidothymidine and Other Antiviral Nucleosides,” The Journal of Biological Chemistry, 1990, 265(11): pp. 6112-6117. |
Hong, C. I. et al., “Nucleoside Conjugates. 7. Synthesis and Antitumor Activity of 1-β-D-Arabinofuranosylcytosine Conjugates of Ether Lipids,” J. Med. Chem., 1986, 29: pp. 2038-2044. |
Aoshima, M. et al., “N4-Behenoyl-1-β-D-Arabinofuranosylcytosine as a Potential New Antitumor Agent,” Cancer Research, 1977, 37: pp. 2481-2486. |
Zalipsky, S. et al., “Attachment of Drugs to Polyethylene Glycols,” Eur. Polym. J., 1983, 19(12): pp. 1177-1183. |
Patel, H. M., et al., “Oral Administration of Insulin by Encapsulation Within Liposomes,” FEBS Letters Vol. 62, No. 1 pgs. 60-63 Feb. 1976. |
Saffran, M., et al., “A Model for the Study of the Oral Administration of Peptide Hormones,” National Research Council of Canada 57, 1979 pp. 548-553. |